This inventor holds 3 USPTO granted patents. Top assignee: Queen's University at Kingston. Active years: 2002-2006.
Company Filing History:
Years Active: 2002-2006
Title: Sandra Marone: Innovator in Neurotrophin Research
Introduction
Sandra Marone is a distinguished inventor based in Kingston, CA. She has made significant contributions to the field of neurotrophin research, holding a total of 3 patents. Her work focuses on innovative methods to inhibit neurotrophin-receptor binding, which has important implications for neurological health.
Latest Patents
One of her latest patents is a method of inhibiting neurotrophin-receptor binding. This invention relates to compositions that inhibit the binding of nerve growth factor to the p75 common neurotrophin receptor. In one embodiment, the compound that inhibits this binding comprises, particularly when bound to nerve growth factor, at least two of the following: a first electronegative atom or functional group positioned to interact with Lys of nerve growth factor; a second electronegative atom or functional group positioned to interact with Lys of nerve growth factor; a third electronegative atom or functional group positioned to interact with Lys of nerve growth factor; a fourth electronegative atom or functional group positioned to interact with Lys of nerve growth factor; and a hydrophobic moiety that interacts with the hydrophobic region formed by Ile, Phe, and Phe of nerve growth factor.
Career Highlights
Sandra Marone is affiliated with Queen's University at Kingston, where she conducts her research. Her innovative work has garnered attention in the scientific community, contributing to advancements in understanding neurotrophin interactions.
Collaborations
Some of her notable coworkers include Gregory M. Ross and Igor L. Shamovsky. Their collaborative efforts have further enhanced the research output and impact of their work in the field.
Conclusion
Sandra Marone is a prominent figure in neurotrophin research, with a focus on innovative methods to inhibit receptor binding. Her contributions are paving the way for advancements in neurological health and treatment options.